All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Trends in Tablet Tooling

August 1, 2014
By Steve Deakin
Article

Pharmaceutical Technology Europe

Pharmaceutical Technology EuropePharmaceutical Technology Europe-08-01-2014
Volume 26
Issue 8

Tool coatings are now seen as an acceptable means of solving production problems, such as sticking and corrosion, resulting in increased product yield.

Surveying the Landscape of Solid-Dosage Manufacturing

Experts take a look at the journey travelled thus far and where pharmaceutical manufacturing is heading over the next decade.

The past decade has seen rapid advances in tablet tooling technology and the acceptance by tablet manufacturers that tooling is a critical part of the tablet production process. Tooling has traditionally been viewed as a consumable item by tablet manufacturers, but this view has changed in recent years as companies invest more in looking after their tooling assets and focus on obtaining a longer life from their punches and dies through improved maintenance and aftercare practices. Tablet manufacturers accept that tablet tooling can have a beneficial effect on the production of good quality tablets, and we have seen a rapid increase in requests for technical support to this end.

Pharmaceutical Technology Europe25th Anniversary Issue

A rapid growth area has been that of coating technology. Tool coatings are now seen as an acceptable means of solving production problems, such as sticking and corrosion, resulting in increased product yield while also extending tooling life. They provide for increased tableting efficiency and output, for example, by reducing the requirement for tools to be taken out of production for additional maintenance work.

Tablet and tool design are also areas that have increased in importance as companies are keen to establish a strong brand identity for their tablet products, while at the same time ensuring that the design can function in the rigours of a tablet production environment. Design is also a key tool by which production problems can be overcome and eliminated. These problems may not always be compression-related issues (e.g., picking) but can also be related to downstream processes such as packaging.

The functionality of the tablet press itself has changed over the past decade as presses are more technologically advanced today. Compression speeds have increased dramatically and, therefore, the demands on the performance of the tooling have increased. The new generation of tablet presses require more exacting tooling standards to be met, and the ability to meet exacting specifications and stringent requirements for optimised surface finish have become particularly important.

The adoption of multi-tip tools has also increased as tablet manufacturers strive to be more efficient and increase productivity in a time where financial resources may be constrained. Multi-tip tooling is now recognised and accepted as a credible alternative to purchasing a new tablet press, for example.

About the Author
Steve Deakin is business development director at I Holland.

Articles in this issue

Serialisation, Aggregation and Authentication
Serialisation, Aggregation and Authentication
Single-Use Systems: Enabling the Future of Biologics Manufacturing
Single-Use Systems: Enabling the Future of Biologics Manufacturing
PTE0814_Cover200-851014-1416901564315.jpg
Protecting Drug Safety
Trends in Single-Use Biomanufacturing
Trends in Single-Use Biomanufacturing
Polymers for Solubility Enhancement
Polymers for Solubility Enhancement
Innovations and Future Trends in HPLC Column Technology
Innovations and Future Trends in HPLC Column Technology
Advances in Film Coating
Advances in Film Coating
Biosimilar Development: 10 Years On
Biosimilar Development: 10 Years On
Single-Use: Game-Changing Technology for the Biopharmaceutical Industry
Single-Use: Game-Changing Technology for the Biopharmaceutical Industry
Supply-Chain Security of Pharmaceutical Starting Materials
Supply-Chain Security of Pharmaceutical Starting Materials
Maturing Aseptic Technologies Create More Flexible Facilities
Maturing Aseptic Technologies Create More Flexible Facilities
Trends in Tablet Tooling
Trends in Tablet Tooling
Technology and QbD Drive Pharma Development
Technology and QbD Drive Pharma Development
PTE0814_Cover200-851015-1416901560801.jpg
Advances in Prefilled Syringe Manufacturing
Collaboration and Innovation in European Medicine Regulation
Collaboration and Innovation in European Medicine Regulation
Recent Videos
Behind the Headlines, Episode 17
Related Content

Gold winners award with three stars | Image Credit: © sergign - stock.adobe.com

ISPE Announces Six 2025 FOYA Category Winners

Patrick Lavery
May 15th 2025
Article

Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Piramal Pharma to Invest $90 Million at Kentucky & Michigan Sites

Patrick Lavery
May 12th 2025
Article

The company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

New CBER Director Appointed

Susan Haigney
May 7th 2025
Article

FDA chooses Dr. Vinay Prasad, MD, MPH, a hematologist-oncologist, to lead the Center for Biologics Evaluation and Research at FDA.


Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
May 7th 2025
Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.

Related Content

Gold winners award with three stars | Image Credit: © sergign - stock.adobe.com

ISPE Announces Six 2025 FOYA Category Winners

Patrick Lavery
May 15th 2025
Article

Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Piramal Pharma to Invest $90 Million at Kentucky & Michigan Sites

Patrick Lavery
May 12th 2025
Article

The company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

New CBER Director Appointed

Susan Haigney
May 7th 2025
Article

FDA chooses Dr. Vinay Prasad, MD, MPH, a hematologist-oncologist, to lead the Center for Biologics Evaluation and Research at FDA.


Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
May 7th 2025
Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.